Biopharmaceutical company Pulmokine has entered into a $1 million investment agreement with Broadview Ventures. The partnership is meant to accelerate…
Articles by Patrícia Silva, PhD
Canadian patients who suffer from pulmonary arterial hypertension (PAH) are raising concerns about the risk of heart…
According to a recent study published online in the American Journal of Managed Care, PH-related hospitalizations…
Clinical stage pharmaceutical company Corbus Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved its…
Actelion Ltd. will present the latest data from its pivotal phase III trial to evaluate selexipag (Uptravi) for…
A recent systematic review titled “Pregnancy and pulmonary arterial hypertension: A clinical conundrum,” highlights that pulmonary arterial…
According to a recent study published in the journal Heart, RV afterload increases in patients with…
Results of a new study are shedding light on the emotional and physical impact that IPF has on both…
Specialty pharmaceutical company SteadyMed Ltd. recently raised $12.2 million in equity financing, co-led by subsidiaries of Federated Investors Inc. and…
Researchers at the School of Medicine at Sapienza University of Rome found that Concentric hypertrophy in the heart right ventricle…
Biopharmaceutical company MediciNova recently announced that MN-001 (tipelukast) has been approved for clinical trials by the…
Cynata Therapeutics Ltd., an Australian regenerative medicine company developing a therapeutic stem cell platform technology called …